Being compared to those carrying G/G at APOC3 rs2070667, the NAFLD patients with G/A or A/A genotype were characterized by low serum levels of PUFA-containing TGs and high-grade lobular inflammation (Figure 1(b)). This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.